AI-focused Stanford leader Dr. Nigam Shah joins BrightSpring (NASDAQ: BTSG) board
Rhea-AI Filing Summary
BrightSpring Health Services, Inc. expanded its board of directors from seven to eight members and appointed Dr. Nigam H. Shah as a Class III director on June 11, 2026. He will also serve on the Board’s Quality and Compliance Committee and be compensated under the company’s standard non-employee director policy.
BrightSpring plans to enter into an indemnification agreement with Dr. Shah in the same form used for its other directors and states there are no related-party transactions requiring disclosure. A press release dated June 12, 2026, describing his appointment is furnished as Exhibit 99.1. The company highlights its nationwide home- and community-based pharmacy and health services, serving over 475,000 individuals daily across all 50 states.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Class III director regulatory
Quality and Compliance Committee regulatory
indemnification agreement regulatory
Regulation FD Disclosure regulatory
Emerging growth company regulatory
Tangible Equity Units financial
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
|||
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 11, 2026, the board of directors (the “Board”) of BrightSpring Health Services, Inc. (the “Company”) increased the number of directors serving on the Board from seven (7) to eight (8) members and appointed Dr. Nigam H. Shah to the Board as a Class III director to fill the resulting vacancy. Dr. Shah will serve until his successor shall be elected and qualified, or until his earlier death, resignation, retirement, disqualification or removal from office. The Board also appointed Dr. Shah to serve as a member of the Quality and Compliance Committee of the Board.
Dr. Shah will be compensated for his service as a director in accordance with the Company’s policy on non-employee director compensation. In connection with Dr. Shah’s appointment to the Board, the Company intends to enter into an indemnification agreement with Dr. Shah in substantially the same form as the Company has entered into with each of the Company’s existing directors and as previously filed with the Securities and Exchange Commission.
There are no arrangements or understandings between Dr. Shah and any other person pursuant to which he was selected as a director. There has been no transaction, nor is there any currently proposed transaction, between Dr. Shah and the Company that would require disclosure under Item 404(a) of Regulation S-K.
Item 7.01 Regulation FD Disclosure.
In connection with the appointment of Dr. Shah to the Board, the Company issued a press release on June 12, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 7.01.
The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated by specific reference in any such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
|
Description |
99.1 |
|
Press Release of BrightSpring Health Services, Inc., dated June 12, 2026. |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
BRIGHTSPRING HEALTH SERVICES, INC. |
|
|
|
|
Date: |
June 12, 2026 |
By: |
/s/ Jennifer Phipps |
|
|
|
Name: Jennifer Phipps |
BrightSpring Health Services, Inc. Welcomes Dr. Nigam H. Shah to Board of Directors
Louisville, Ky., June 12, 2026 — BrightSpring Health Services (“BrightSpring” or “the Company”) (NASDAQ: BTSG), a leading provider of home- and community-based pharmacy and health services for complex populations, announced that Dr. Nigam H. Shah was appointed as a Class III member of the Board of Directors on June 11, 2026. Dr. Shah will also serve as a member of the Board’s Quality and Compliance Committee.
Dr. Shah joined Stanford University as an Assistant Professor of Medicine in 2011, was tenured in 2015, and promoted to Professor of Medicine and Biomedical Data Science in 2020. Dr. Shah currently serves as the Chief Data Scientist at Stanford Healthcare and Associate Dean for Health Information and Data Science. His work focuses on leveraging technology and data insights to improve patient outcomes while bringing artificial intelligence (“AI”) to clinical use, safely, ethically and cost-effectively. He has co-founded three companies and serves on the Boards of Prealize Health and Atropos Health. Dr. Shah is also a co-founder of the Coalition for Health AI (CHAI).
“We are excited to welcome Dr. Nigam Shah, as a thought leader in information technology and artificial intelligence in healthcare, to our board,” said BrightSpring President and CEO Jon Rousseau. “Nigam has decades of leadership experience in the healthcare field, along with unique insights into how technology and artificial intelligence can drive both clinician and patient success, from the lens of a researcher and business leader. Dr. Shah will be a valued voice as we continue to work to create better solutions for patients and address healthcare challenges and opportunities.”
“I’m honored to join BrightSpring as a new Board member to help them succeed in their mission to better the lives of patients and improve communities,” said Dr. Nigam Shah. “It has long been my focus to make a difference in healthcare through technology. I believe my years of service in business and as a professor and researcher will bring a unique perspective to further the use of technology and AI for BrightSpring, patients, and other key stakeholders in healthcare.”
Throughout his career, Dr. Shah has received countless awards and recognitions for his work, including being a Fellow of the Association of American Physicians, a Fellow of the American College of Medical Informatics, a Stanford ISP Star Award, and being inducted into the American Society for Clinical Investigation.
# # #
About BrightSpring Health Services
BrightSpring Health Services provides complementary home- and community-based health solutions for complex populations in need of specialized and/or chronic care. Through the Company’s service lines, including pharmacy, home health care, and rehabilitation, we provide comprehensive and more integrated care and clinical solutions in all 50 states to over 475,000 customers, clients and patients daily. BrightSpring has consistently demonstrated strong and industry-leading quality metrics across its services lines, while improving the health and quality of life for high-need individuals and reducing overall healthcare system costs.
Contact
Investor Relations:
David Deuchler, CFA
Gilmartin Group LLC
ir@brightspringhealth.com
Media Contact:
Leigh White
leigh.white@brightspringhealth.com
502.630.7412